Vaccine Center News and Releases

Sarah George, M.D. (Infectious Diseases) was interviewed on KMOX-AM 1120 about her upcoming Zika virus vaccine clinical trial.  Read More Here>>>>

Stopping Zika: Saint Louis University to Launch Human Vaccine Trial
Read More Here>>>>


Zika research led at Saint Louis University by Dan Hoft, M.D., Ph.D. (Infectious Diseases) was covered on Healio.
Read More Here>>>>

‘Missouri Medicine' Turns to SLU for Vaccine Research Insights
Saint Louis University researchers are attacking influenza on multiple fronts as they search for a universal vaccine that protects people from the flu virus that often mutates year to year with deadly consequences. Read More>>>

 

SLU Vaccine Researcher Named to NIH Panel

Robert Belshe, M.D., director of Saint Louis University's Center for Vaccine Development, has been appointed to serve on the National Institutes of Health's (NIH) main advisory panel on allergies and infectious diseases.

Dr Frey Infectious Diseases Researcher Honored as a YWCA Leader of Distinction
ST. LOUIS -- Sharon Frey, M.D., clinical director of Saint Louis University's Center for Vaccine Development and professor of infectious diseases, allergy and immunology, was honored as one of the YWCA's Leaders of Distinction on Dec. 6.

 

SLU Tests New Meningitis Vaccine
ST. LOUIS -- Scientists at Saint Louis University's Center for Vaccine Development will conduct a clinical trial of an investigational vaccine for meningococcal B disease, the only remaining predominant meningococcal serogroup for which no vaccine is available. The trial is part of a national study.

SLU Initiates Tularemia Vaccine Research Study
Researchers at Saint Louis University's Center for Vaccine Development are studying whether an investigational vaccine can protect people from tularemia, commonly known as rabbit fever, which is an illness that strikes people and animals

 

SLU Initiates Tularemia Vaccine Research Study
Researchers at Saint Louis University's Center for Vaccine Development are studying whether an investigational vaccine can protect people from tularemia, commonly known as rabbit fever, which is an illness that strikes people and animals

 

SLU Findings: Don't Pitch Stockpiled Avian Flu Vaccine
Vaccine that Doesn’t Match Today’s Bird Flu Can Be Valuable in Fighting a Potential Pandemic

A year from now, babies could get higher dose of flu vaccine

St. Louis, MO (KSDK) -- A year from now, babies could be getting a higher dose of flu vaccine than they'll get this fall.

SLU Studies New Smallpox Vaccine
Volunteers Sought for NIH-Funded Research Study, One of Two U.S. Sites

Double Flu Fighter: H1N1 Flu Vaccine Likely Works for 1918 Flu
The vaccine for last year's pandemic H1N1 influenza also appears to protect against the 1918 Spanish influenza virus, which killed approximately 50 million world-wide, according to new research published in the online journal Nature Communications.

Fighting Dengue: SLU Studies Investigational Vaccine
Center for Vaccine Development Is Only Site for NIH-Sponsored Research Study

Sponsored by the National Institutes of Health (NIH), Saint Louis University's Center for Vaccine Development is conducting research of an investigational vaccine designed to prevent people from contracting dengue, a potentially lethal virus that has rapidly spread around the world.  Read More>>>

SLU Studies Seasonal Flu Vaccine for Pregnant Women
NIH-Funded Clinical Trial to Draw About 200 Women Across the Country
To read the entire article please visit ClinicalTrials.gov

Higher purpose. Greater good.
© 1818 - 2017  SAINT LOUIS UNIVERSITY   |   Disclaimer   |  Mobile Site
St. Louis   |   Madrid